Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma.
Buhl R, Tanase AM, Hosoe M, Cao W, Demin I, Bartels C, Jauernig J, Ziegler D, Patalano F, Hederer B, Kanniess F, Tillmann HC. Buhl R, et al. Among authors: tillmann hc. Pulm Pharmacol Ther. 2020 Jun;62:101919. doi: 10.1016/j.pupt.2020.101919. Epub 2020 May 7. Pulm Pharmacol Ther. 2020. PMID: 32387408 Free article.
Effect of Indacaterol/Glycopyrronium on Pulmonary Perfusion and Ventilation in Hyperinflated Patients with Chronic Obstructive Pulmonary Disease (CLAIM). A Double-Blind, Randomized, Crossover Trial.
Vogel-Claussen J, Schönfeld CO, Kaireit TF, Voskrebenzev A, Czerner CP, Renne J, Tillmann HC, Berschneider K, Hiltl S, Bauersachs J, Welte T, Hohlfeld JM. Vogel-Claussen J, et al. Among authors: tillmann hc. Am J Respir Crit Care Med. 2019 May 1;199(9):1086-1096. doi: 10.1164/rccm.201805-0995OC. Am J Respir Crit Care Med. 2019. PMID: 30641027 Clinical Trial.
Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study.
Watz H, Hohlfeld JM, Singh D, Beier J, Diamant Z, Liu J, Hua S, Abd-Elaziz K, Pinot P, Jones I, Tillmann HC. Watz H, et al. Among authors: tillmann hc. Respir Res. 2020 Apr 15;21(1):87. doi: 10.1186/s12931-020-01349-5. Respir Res. 2020. PMID: 32295593 Free PMC article. Clinical Trial.
Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once-daily inhalation as a combination in healthy subjects.
Vaidya S, Jauernig J, Ethell B, Abdallah N, Machineni S, Drollmann A, Heudi O, Last S, Hahn M, Radhakrishnan R, Ignatenko S, Tillmann HC. Vaidya S, et al. Among authors: tillmann hc. Pulm Pharmacol Ther. 2020 Oct;64:101964. doi: 10.1016/j.pupt.2020.101964. Epub 2020 Oct 6. Pulm Pharmacol Ther. 2020. PMID: 33035700 Free article. Clinical Trial.
Population Pharmacokinetic Analysis of Indacaterol/Glycopyrronium/Mometasone Furoate After Administration of Combination Therapies Using the Breezhaler® Device in Patients with Asthma.
Bartels C, Jain M, Yu J, Tillmann HC, Vaidya S. Bartels C, et al. Among authors: tillmann hc. Eur J Drug Metab Pharmacokinet. 2021 Jul;46(4):487-504. doi: 10.1007/s13318-021-00689-x. Epub 2021 May 22. Eur J Drug Metab Pharmacokinet. 2021. PMID: 34024035 Free PMC article.
Dose bridging data for mometasone furoate in once-daily fixed-dose inhaled combinations of mometasone furoate/indacaterol and mometasone furoate/ indacaterol/glycopyrronium in patients with asthma.
Buhl R, Nikolaev I, Tillmann HC, Vaidya S, Bartels C, Jain M, Jauernig J, Kerstjens HAM. Buhl R, et al. Among authors: tillmann hc. Pulm Pharmacol Ther. 2021 Oct;70:102068. doi: 10.1016/j.pupt.2021.102068. Epub 2021 Jul 28. Pulm Pharmacol Ther. 2021. PMID: 34329722 Free article. Review.
47 results